BIO-MEDICINE: The first patients have entered a Phase 2 clinical trial of a innovative targeted drug treatment, Aptocine(TM) (talaporfin sodium), for benign prostatic hyperplasia (enlarged prostate). READ MORE>
Posts Tagged ‘innovative targeted drug treatment’
New drug for treating benign prostatic hyperplasia enters phase 2 clinical trial in US
Posted in Enlarged prostate, PROSTATE CANCER, Treatment news, tagged Aptocine(TM) (talaporfin sodium), benign prostatic hyperplasia, BIO-MEDICINE, Enlarged prostate, innovative targeted drug treatment, Light Sciences Oncology Inc., Phase 2 clinical trial, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate on August 20, 2009| Leave a Comment »
Blog Stats
- 295,393 hits
Search
Prostablog RSS – click here- Still here, still clear – 2020 June 24, 2020
- PSA treachery hits close to home May 18, 2019
- Coming up to a decade clear June 4, 2018
PROSTABLOG pages
Category cloud
COMMENTS
